BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 32710267)

  • 21. Heterogeneity is a common ground in familial hypomagnesemia with hypercalciuria and nephrocalcinosis caused by CLDN19 gene mutations.
    Vall-Palomar M; Burballa C; Claverie-Martín F; Meseguer A; Ariceta G
    J Nephrol; 2021 Dec; 34(6):2053-2062. PubMed ID: 33929692
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Familial hypomagnesaemia with hypercalciuria and nephrocalcinosis: the first four patients in Serbia.
    Peco-Antić A; Konrad M; Milosevski-Lomić G; Dimitrijević N
    Srp Arh Celok Lek; 2010; 138(5-6):351-5. PubMed ID: 20607983
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Familial hypomagnesemia with hypercalciuria and nephrocalcinosis (FHHNC): report of three cases with a novel mutation in CLDN19 gene.
    Al-Shibli A; Konrad M; Altay W; Al Masri O; Al-Gazali L; Al Attrach I
    Saudi J Kidney Dis Transpl; 2013 Mar; 24(2):338-44. PubMed ID: 23538362
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Haplotype analysis of CLDN19 single nucleotide polymorphisms in Spanish patients with familial hypomagnesemia with hypercalciuria and nephrocalcinosis.
    Martin-Nuñez E; Cordoba-Lanus E; Gonzalez-Acosta H; Oliet A; Izquierdo E; Claverie-Martin F
    World J Pediatr; 2015 Aug; 11(3):272-5. PubMed ID: 25410674
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Familial hypomagnesemia with hypercalciuria and nephrocalcinosis: variable phenotypic expression in three affected sisters from Mexican ancestry.
    Arteaga ME; Hunziker W; Teo AS; Hillmer AM; Mutchinick OM
    Ren Fail; 2015 Feb; 37(1):180-3. PubMed ID: 25366522
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel homozygous W99G mutation in CLDN-16 gene causing familial hypomagnesemic hypercalciuric nephrocalcinosis in Turkish siblings.
    Alparslan C; Öncel EP; Akbay S; Alaygut D; Mutlubaş F; Tatlı M; Konrad M; Yavaşcan Ö; Kasap-Demir B
    Turk J Pediatr; 2018; 60(1):76-80. PubMed ID: 30102483
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Claudin-19 mutations and clinical phenotype in Spanish patients with familial hypomagnesemia with hypercalciuria and nephrocalcinosis.
    Claverie-Martín F; García-Nieto V; Loris C; Ariceta G; Nadal I; Espinosa L; Fernández-Maseda Á; Antón-Gamero M; Avila A; Madrid Á; González-Acosta H; Córdoba-Lanus E; Santos F; Gil-Calvo M; Espino M; García-Martinez E; Sanchez A; Muley R;
    PLoS One; 2013; 8(1):e53151. PubMed ID: 23301036
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical and molecular characterization of Turkish patients with familial hypomagnesaemia: novel mutations in TRPM6 and CLDN16 genes.
    Guran T; Akcay T; Bereket A; Atay Z; Turan S; Haisch L; Konrad M; Schlingmann KP
    Nephrol Dial Transplant; 2012 Feb; 27(2):667-73. PubMed ID: 21669885
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutation in the tight-junction gene claudin 19 (CLDN19) and familial hypomagnesemia, hypercalciuria, nephrocalcinosis (FHHNC) and severe ocular disease.
    Naeem M; Hussain S; Akhtar N
    Am J Nephrol; 2011; 34(3):241-8. PubMed ID: 21791920
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of tight junctions in paracellular ion transport in the renal tubule: lessons learned from a rare inherited tubular disorder.
    Haisch L; Almeida JR; Abreu da Silva PR; Schlingmann KP; Konrad M
    Am J Kidney Dis; 2011 Feb; 57(2):320-30. PubMed ID: 21186073
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Novel Mutation in CLDN16 Gene Causing Familial Hypomagnesemia, Hypercalciuria, Nephrocalcinosis in An Iranian Family.
    Malakoutian T; Madadi B; Saber S
    Iran J Kidney Dis; 2022 May; 16(3):209-213. PubMed ID: 35714216
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Familial hypomagnesaemia, Hypercalciuria and Nephrocalcinosis associated with a novel mutation of the highly conserved leucine residue 116 of Claudin 16 in a Chinese patient with a delayed diagnosis: a case report.
    Lu J; Zhao X; Paiardini A; Lang Y; Bottillo I; Shao L
    BMC Nephrol; 2018 Jul; 19(1):181. PubMed ID: 30005619
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Claudin-16 and claudin-19 interact and form a cation-selective tight junction complex.
    Hou J; Renigunta A; Konrad M; Gomes AS; Schneeberger EE; Paul DL; Waldegger S; Goodenough DA
    J Clin Invest; 2008 Feb; 118(2):619-28. PubMed ID: 18188451
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Two heterozygous mutations of CLDN16 in a Japanese patient with FHHNC.
    Tajima T; Nakae J; Fujieda K
    Pediatr Nephrol; 2003 Dec; 18(12):1280-2. PubMed ID: 14586675
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Claudin-16 Deficiency Impairs Tight Junction Function in Ameloblasts, Leading to Abnormal Enamel Formation.
    Bardet C; Courson F; Wu Y; Khaddam M; Salmon B; Ribes S; Thumfart J; Yamaguti PM; Rochefort GY; Figueres ML; Breiderhoff T; Garcia-Castaño A; Vallée B; Le Denmat D; Baroukh B; Guilbert T; Schmitt A; Massé JM; Bazin D; Lorenz G; Morawietz M; Hou J; Carvalho-Lobato P; Manzanares MC; Fricain JC; Talmud D; Demontis R; Neves F; Zenaty D; Berdal A; Kiesow A; Petzold M; Menashi S; Linglart A; Acevedo AC; Vargas-Poussou R; Müller D; Houillier P; Chaussain C
    J Bone Miner Res; 2016 Mar; 31(3):498-513. PubMed ID: 26426912
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Familial Hypomagnesemia, Hypercalciuria and Nephrocalcinosis with Novel Mutation.
    Margabandhu S; Doshi M
    Indian J Nephrol; 2019; 29(1):57-61. PubMed ID: 30814796
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amelogenesis imperfecta in familial hypomagnesaemia and hypercalciuria with nephrocalcinosis caused by CLDN19 gene mutations.
    Yamaguti PM; Neves FA; Hotton D; Bardet C; de La Dure-Molla M; Castro LC; Scher MD; Barbosa ME; Ditsch C; Fricain JC; de La Faille R; Figueres ML; Vargas-Poussou R; Houillier P; Chaussain C; Babajko S; Berdal A; Acevedo AC
    J Med Genet; 2017 Jan; 54(1):26-37. PubMed ID: 27530400
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In-Depth Bioinformatic Study of the CLDN16 Gene and Protein: Prediction of Subcellular Localization to Mitochondria.
    Rouka E; Liakopoulos V; Gourgoulianis KI; Hatzoglou C; Zarogiannis SG
    Medicina (Kaunas); 2019 Jul; 55(8):. PubMed ID: 31357502
    [No Abstract]   [Full Text] [Related]  

  • 39. Targeted deletion of murine Cldn16 identifies extra- and intrarenal compensatory mechanisms of Ca2+ and Mg2+ wasting.
    Will C; Breiderhoff T; Thumfart J; Stuiver M; Kopplin K; Sommer K; Günzel D; Querfeld U; Meij IC; Shan Q; Bleich M; Willnow TE; Müller D
    Am J Physiol Renal Physiol; 2010 May; 298(5):F1152-61. PubMed ID: 20147368
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Familial hypomagnesemia with hypercalciuria and nephrocalcinosis associated with CLDN16 mutations.
    Kang JH; Choi HJ; Cho HY; Lee JH; Ha IS; Cheong HI; Choi Y
    Pediatr Nephrol; 2005 Oct; 20(10):1490-3. PubMed ID: 16047219
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.